Ignite Creation Date:
2024-05-05 @ 5:23 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00446134
Status:
COMPLETED
Last Update Posted:
2012-07-27
First Post:
2007-03-08
Brief Title:
Taribavirin Phase 2 Dose Finding Study for the Treatment of Hepatitis C Virus HCV
Sponsor:
Bausch Health Americas Inc
Organization:
Bausch Health Americas Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Chronic Hepatitis C |
Keywords:
| Name | View |
|---|---|
| Phase 2b Dose-Ranging Study | View |